RELATED CONTENT
NEWS
- Gilead's Truvada cut risk of HIV infection by up to 78% in heterosexuals
- Express Scripts $29.1 billion bid for Medco will hit US FTC scrutiny and squeeze pharma
- Familial cholesterol tests from Gen-Probe, Progenika fall short of NICE expectations
- BioSante to begin Phase I trial of melanoma vaccine at Johns Hopkins
FEATURES
Other Informa Features

